GT Biopharma (GTBP) had the highest return between September 1, 2011 and January 31, 2013 by a US stock in the Nasdaq Composite (IXIC), returning 1,037,288,035.6%.
| ASSET | DATE | % RETURN |
|---|---|---|
GT Biopharma (GTBP) | 9/1/2011 - 1/31/2013 | 1,037,288,035.59% |
Flux Power (FLUX) | 9/1/2011 - 1/31/2013 | 13,693.1% |
Rezolute (RZLT) | 9/1/2011 - 1/31/2013 | 2,207.68% |
Coda Octopus (CODA) | 9/1/2011 - 1/31/2013 | 990% |
Security National Financial (SNFCA) | 9/1/2011 - 1/31/2013 | 798.99% |
Patrick Industries (PATK) | 9/1/2011 - 1/31/2013 | 724.2% |
Kazia Therapeutics Ltd ADR (KZIA) | 9/1/2011 - 1/31/2013 | 633.28% |
Consumer Portfolio Services (CPSS) | 9/1/2011 - 1/31/2013 | 616.67% |
Algorhythm (RIME) | 9/1/2011 - 1/31/2013 | 600% |
Mawson Infrastructure (MIGI) | 9/1/2011 - 1/31/2013 | 473.08% |
Expedia (EXPE) | 9/1/2011 - 1/31/2013 | 433.69% |
Paysign (PAYS) | 9/1/2011 - 1/31/2013 | 400% |
Travere Therapeutics (TVTX) | 9/1/2011 - 1/31/2013 | 400% |
Maywood Acquisition Corp Class A Ordinary Shares (MAYA) | 9/1/2011 - 1/31/2013 | 375% |
Where Food Comes From (WFCF) | 9/1/2011 - 1/31/2013 | 357.14% |
ACADIA Pharmaceuticals (ACAD) | 9/1/2011 - 1/31/2013 | 333.81% |
BioLife Solutions (BLFS) | 9/1/2011 - 1/31/2013 | 330.77% |
MiMedx (MDXG) | 9/1/2011 - 1/31/2013 | 306.54% |
Xpel (XPEL) | 9/1/2011 - 1/31/2013 | 300% |
Sarepta Therapeutics (SRPT) | 9/1/2011 - 1/31/2013 | 266.53% |
TOMI Environmental Solutions (TOMZ) | 9/1/2011 - 1/31/2013 | 252.94% |
Lendingtree (TREE) | 9/1/2011 - 1/31/2013 | 249.92% |
Alnylam Pharmaceuticals (ALNY) | 9/1/2011 - 1/31/2013 | 244.71% |
Stratasys (SSYS) | 9/1/2011 - 1/31/2013 | 238.28% |
Astrana Health (ASTH) | 9/1/2011 - 1/31/2013 | 233.69% |
